In another study comparing ibrutinib and R406, it was demonstrated that R406 has a stronger pro-apoptotic effect through Mcl-1 downregulation than ibrutinib in chronic lymphocytic leukemia (CLL) samples [46]. This evidence concerns the gene MCL1 and B-cell chronic lymphocytic leukemia.